Paul Peter Tak, M.D., Ph.D., FMedSci
DirectoratCandel Therapeutics· In proxies 2023–2025
Paul Peter Tak, M.D., Ph.D., FMedSci is Director of Candel Therapeutics.
Experience
- Candel TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +486%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?